primary antibody for terk (Merck KGaA)
Structured Review
Primary Antibody For Terk, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibody+for+terk/primary+antibody+for+terk/pm34285375-75-10-42
Average 90 stars, based on 1 article reviews
Images
Related Articles
Blocking Assay:Article Title: Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice. Article Snippet: Rivaroxaban (Riv), a direct factor Xa (FXa) inhibitor, exerts anti-inflammatory effects in addition to anticoagulation.. However, its role in cardiovascular remodeling is largely unknown.. We tested the hypothesis that Riv attenuates the progression of cardiac hypertrophy and fibrosis induced by continuous activation of the renin–angiotensin system (RAS) in renin-overexpressing hypertensive transgenic (Ren-Tg) mice. Incubation:Article Title: Rivaroxaban attenuates cardiac hypertrophy by inhibiting protease-activated receptor-2 signaling in renin-overexpressing hypertensive mice. Article Snippet: Rivaroxaban (Riv), a direct factor Xa (FXa) inhibitor, exerts anti-inflammatory effects in addition to anticoagulation.. However, its role in cardiovascular remodeling is largely unknown.. We tested the hypothesis that Riv attenuates the progression of cardiac hypertrophy and fibrosis induced by continuous activation of the renin–angiotensin system (RAS) in renin-overexpressing hypertensive transgenic (Ren-Tg) mice. |

